Pradeep Bathina
Overview
Explore the profile of Pradeep Bathina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ofer-Friedman H, Shefler C, Sharma S, Tirosh A, Tal-Jasper R, Kandipalli D, et al.
Infect Control Hosp Epidemiol
. 2015 May;
36(8):981-5.
PMID: 25990361
A recent, frequently quoted study has suggested that for bloodstream infections (BSIs) due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL) Escherichia coli, treatment with β-lactam/β-lactamase inhibitors (BLBLIs) might be equivalent to treatment...
2.
Hayakawa K, Martin E, Gudur U, Marchaim D, Dalle D, Alshabani K, et al.
Antimicrob Agents Chemother
. 2014 May;
58(7):3968-75.
PMID: 24798267
Vancomycin-resistant enterococci (VRE) are a growing health problem, and uncertainties exist regarding the optimal therapy for bloodstream infection due to VRE. We conducted systematic comparative evaluations of the impact of...
3.
Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, et al.
Antimicrob Agents Chemother
. 2013 Jun;
57(8):4010-8.
PMID: 23752516
A case-case-control study was conducted to identify independent risk factors for recovery of Escherichia coli strains producing CTX-M-type extended-spectrum β-lactamases (CTX-M E. coli) within a large Southeastern Michigan medical center....
4.
Campbell M, Marchaim D, Pogue J, Sunkara B, Bheemreddy S, Bathina P, et al.
Ann Pharmacother
. 2012 Dec;
46(12):1587-97.
PMID: 23212935
Background: Guidelines recommend that agents other than vancomycin be considered for some types of infection due to methicillin-resistant Staphylococcus aureus (MRSA) when the minimum inhibitory concentration (MIC) to vancomycin is...
5.
Hayakawa K, Marchaim D, Palla M, Gudur U, Pulluru H, Bathina P, et al.
Antimicrob Agents Chemother
. 2012 Oct;
57(1):49-55.
PMID: 23070173
Although much is known about vancomycin-resistant (VR) Enterococcus faecium, little is known about the epidemiology of VR Enterococcus faecalis. The predilection of VR E. faecalis to transfer the vancomycin resistance...
6.
Hayakawa K, Marchaim D, Martin E, Tiwari N, Yousuf A, Sunkara B, et al.
Antimicrob Agents Chemother
. 2012 Feb;
56(5):2452-8.
PMID: 22354290
In published studies, cohorts of patients with bacteremia due to vancomycin-resistant Enterococcus (VRE) have predominantly been infected with Enterococcus faecium. Little is known about the epidemiology and outcomes associated with...